Cell-Penetrating TLR Inhibitor Peptide Ameliorates Experimental Autoimmune Encephalomyelitis and Promotes Efferocytosis in Microglia and Macrophages
International Journal of Molecular Sciences · 12.11.2026 · 27 (22) · 10132
DOI: 10.3390/ijms272210132 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.11.2026. Verfasst von Yejin Lee und 4 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT.
Abstract (Originalsprache)
Toll-like receptor (TLR) signaling contributes to inflammatory activation during autoimmune neuroinflammation. We previously demonstrated that a cell-penetrating TLR inhibitory peptide (cpTLR-i), designed to interfere with TLR adaptor recruitment, alleviated experimental colitis through functional modulation of macrophages. Here, we investigated the therapeutic and immunomodulatory effects of cpTLR-i in experimental autoimmune encephalomyelitis (EAE). cpTLR-i suppressed inflammatory mediator production in activated BV2 microglia while preserving MHC class II expression. Systemic cpTLR-i treatment delayed EAE onset, reduced disease severity, and attenuated CNS inflammation and demyelination. Immune profiling revealed reduced granulocyte accumulation and type 1 CD4+ T cells, increased FoxP3+ regulatory T cells, and functional reprogramming of microglia and infiltrating macrophages. Notably, cpTLR-i enhanced apoptotic-cell uptake by microglia and macrophages in vitro and induced an efferocytosis-associated program characterized by increased LXRα and CD36 expression even in the absence of exogenous TLR ligands. Pharmacological inhibition further implicated LXR signaling in this response, while cpTLR-i altered SOCS/STAT3 signaling, revealing an unexpected association between modulation of TLR signaling and signaling networks involved in the regulation of efferocytosis. These findings demonstrate that cpTLR-i not only suppresses inflammatory responses but also promotes pro-resolving functions of microglia and macrophages, suggesting that selective modulation of TLR signaling represents a potential therapeutic strategy for neuroinflammatory diseases.
Förderung
- Ministry of Science and ICT
Zitieren
APA
Lee, Y., Park, H., Pak, S., Kim, M., & Lee, K. (2026). Cell-Penetrating TLR Inhibitor Peptide Ameliorates Experimental Autoimmune Encephalomyelitis and Promotes Efferocytosis in Microglia and Macrophages. International Journal of Molecular Sciences, 27(22), 10132. https://doi.org/10.3390/ijms272210132
Vancouver
Lee Y, Park H, Pak S, Kim M, Lee K. Cell-Penetrating TLR Inhibitor Peptide Ameliorates Experimental Autoimmune Encephalomyelitis and Promotes Efferocytosis in Microglia and Macrophages. International Journal of Molecular Sciences. 2026;27(22):10132. doi:10.3390/ijms272210132
BibTeX
@article{Lee2026,
author = {Lee, Yejin and Park, Hangyeol and Pak, Seongwon and Kim, Misu and Lee, Keunwook},
title = {Cell-Penetrating TLR Inhibitor Peptide Ameliorates Experimental Autoimmune Encephalomyelitis and Promotes Efferocytosis in Microglia and Macrophages},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10132},
doi = {10.3390/ijms272210132}
}
EUVIMED